Source: AVMA

In the latest government spending bill, Congress has passed legislation to reauthorize the Animal Drug User Fee Act (ADUFA) and the Animal Generic Drug User Fee Act (AGDUFA). These laws, reauthorized every five years, are crucial for providing a predictable pathway to market for both innovative and generic animal drugs. The legislation, endorsed by the American Veterinary Medical Association (AVMA), utilizes user fees to enhance the U.S. Food and Drug Administration Center for Veterinary Medicine’s (FDA CVM) review of these drugs.

AVMA has actively participated in the reauthorization process by providing verbal and written feedback to FDA CVM, highlighting the potential of these programs to provide veterinarians with safer and more effective animal drugs. The reauthorization is seen as essential to bolstering the availability of safe and effective treatment options for veterinarians, ultimately improving animal welfare. Dr. Lori Teller, AVMA Immediate Past President, testified before Congress to stress the importance of reauthorizing ADUFA and AGDUFA earlier this year.

Read the full story HERE: